![Shou Peng Lai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 65 M $ al 31/07/2026
Shou Peng Lai has a career history that includes founding Nanjing Leads Biolabs Co., Ltd. in 2012.
Dr. Lai is the founder and holds the title of Executive Director, Chief Strategic Officer & EVP since 2015.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/06/2026 | 6.384.821 ( 3,23 % ) | 43 M $ | 31/07/2026 | |
| 25/07/2025 | 3.192.410 ( 2,04 % ) | 22 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NANJING LEADS BIOLABS CO., LTD. | Fundador | 27/11/2012 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 1 |
|---|---|
Nanjing Leads Biolabs Co., Ltd.
 Nanjing Leads Biolabs Co., Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for discovery, development and commercialization of oncology therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
